Bio-Rad (BIO) Shares Tumble as Credit Agricole Downgrades from Outperform to Underperform
BIO Hot Sheet
Rating Summary:0 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Shares of Bio-Rad Labs (NYSE: BIO) have sunk midday Tuesday following an intraday downgrade from Credit Agricole's Paul Knight. The stock is now down 0.8 percent to $102.25.
Knight now rates Bio-Rad shares an Underperform, down from Outperform previously. The analyst cut his price target on the stock from $110 to $108.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
Knight now rates Bio-Rad shares an Underperform, down from Outperform previously. The analyst cut his price target on the stock from $110 to $108.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- JPMorgan Upgrades Companhia Brasileira de Distrib (CBD) to Neutral
- Wells Fargo Upgrades Aeropostale, Inc. (ARO) to Market Perform; Risk/Reward Even Given Improving Trends
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
